Diabetes Mellitus, Type 2ObesityMetforminSulfonylurea CompoundsInsulinBlood GlucoseDrug Therapy, CombinationHypoglycemic AgentsWhen diet therapy is no longer effective in keeping the fasting plasma glucose level < 6 mmol l-1, a basal insulin supplement from a long-acting insulin such as ultralente can ...
Insulin therapy in type 2 diabetesJill Hill
Type 2 diabetes is a lifelong disease that keeps your body from using insulin the way it should. People who are middle-aged or older are most likely to get this kind of diabetes. It used to be called adult-onset diabetes or diabetes mellitus. But type 2 diabetes also affects kids andtee...
The dual aspects of type 2 diabetes, insulin resistance and insulin deficiency, are important factors in therapy selection and the subsequent reponse to therapy. Most patients have gradually increasing needs for additional therapy. Some patients require combination pharmacologic therapy at the time of ...
Insulin therapy provides effective glycemic control in patients with diabetes who have deficient beta-cell function and insulin secretion. Subjects with type 2 diabetes not adequately controlled on oral agents or incretin therapies can initiate basal insulin replacement to correct fasting hyperglycemia. Whil...
Type 2 diabetes is a condition in which the cells cannot use blood sugar efficiently to meet the body’s needs. Learn about symptoms, causes, vs. type 1 diabetes, diet, exercise, treatment, insulin, medications, life expectancy, and other lifestyle chang
This drug class can help to reduce your risk of heart attack and stroke. So, it is prescribed to people who are at high risk of these conditions. A Look at Insulin Therapy Type 2 diabetes management through insulin therapy has grown in popularity for type 2 diabetes patients because of ...
In this edition of ‘Then and now’ the initial studies by J.C. Pickup and colleagues supporting the hypothesis that type 2 diabetes is caused by
There have been a number of studies of the impact of insulin therapy on well-being and quality of life (QOL) in Type 2 diabetes. In the large-scale UK Prospective Diabetes Study (UKPDS), randomisation to insulin therapy was not associated with a significant change in QOL in a subset of ...
Importance Once-weekly insulin icodec could provide a simpler dosing alternative to daily basal insulin in people with type 2 diabetes. Objective To evaluate the efficacy and safety of once-weekly icodec vs once-daily insulin degludec in people with insulin-naive type 2 diabetes. Design, Setting,...